SNAP-8 10mg

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

Do not start, stop, combine, or change a protocol based only on website content.
Emergency symptoms require urgent medical care, not a website or routine follow-up message.

Quickstart Highlights

SNAP-8 (Acetyl Octapeptide-3) is a synthetic octapeptide that mimics the N-terminal end of the SNAP-25 protein involved in neuromuscular signalling[1][5]. In real-world use SNAP-8 is a topical cosmetic ingredient (typically 3–10% in anti-wrinkle serums and creams, listed as INCI Acetyl Octapeptide-3) — it is not an approved injectable drug and has no published efficacy or safety data for the subcutaneous route this page describes. This educational page outlines a hypothetical once-daily subcutaneous approach with a dilution chosen so doses land on easy-to-read insulin-syringe marks, but the validated use is topical. It is an unapproved cosmetic peptide, not a medicine — the injectable protocol below is off-label, unstudied and presented for research and educational use only.

Add 3.0 mL bacteriostatic water to one 10 mg vial → ~3.33 mg/mL (3,330 mcg/mL), the largest practical dilution for accurate dosing.
330–1,000 mcg once daily, titrated upward gradually across an 8–12 week (optionally 16-week) course.
At ~3.33 mg/mL, 1 unit ≈ 33.3 mcg; 330 mcg ≈ 10 units and 1,000 mcg ≈ 30 units on a U-100 syringe.
Lyophilized: store at −20 °C (−4 °F); once reconstituted, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the solution.
Important: Start with the Prep & Injection Guide — it covers the preparation and safety basics every protocol on this site assumes.

Dosing & Reconstitution Guide

A single practical dilution with accurate once-daily dosing, step by step

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

Phase / Week(s)	Dose & Frequency	Volume (U-100 units / mL)
Weeks 1–4	330 mcg (1× daily)	~10 units (0.10 mL)
Weeks 5–8	500 mcg (1× daily)	~15 units (0.15 mL)
Weeks 9–12	1,000 mcg (1× daily)	~30 units (0.30 mL)
Weeks 13–16 (optional)	1,000 mcg (1× daily)	~30 units (0.30 mL)

Reconstitute: Add 3.0 mL bacteriostatic water to one 10 mg vial → final concentration ~3.33 mg/mL (3,330 mcg/mL).
Typical daily range: 330–1,000 mcg once daily, raised gradually over an 8–12 week course (optional 16-week extension).
Easy measuring: At ~3.33 mg/mL, 1 unit ≈ 33.3 mcg on a U-100 syringe. Using the large 3.0 mL dilution keeps every dose on whole-unit marks (10–30 units) for reliable measuring accuracy.
Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the mixed solution.
Frequency: one subcutaneous injection each day, titrating up as tolerated. This educational schedule mirrors the once-daily SC titration described for this peptide’s injectable use[3][4]. These figures come from an unstudied educational protocol for an injectable route, not from approved human dosing.

Reconstitution Steps

Draw 3.0 mL of bacteriostatic water into a sterile syringe.

Release it slowly down the vial’s inner wall to limit foaming.
Swirl or roll gently until fully dissolved — don’t shake.
Label with the date and concentration, then refrigerate at 2–8 °C (35.6–46.4 °F), shielded from light.
The 3.0 mL dilution is chosen so each dose reads on whole-unit marks (10–30 units), where U-100 syringe markings are most precise. Avoid freezing the reconstituted solution, since freeze–thaw can denature the peptide.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Quantities below assume an 8–16 week course of once-daily injections with gradual titration.

One 10 mg vial covers roughly 30 doses at the 330 mcg starting dose (fewer at higher titration steps), so plan vials against your daily dose and cycle length.
8 weeks: ~8 vials
12 weeks: ~12 vials
16 weeks: ~16 vials
Per injection: 1 syringe
8 weeks (once daily): ~56 syringes
16 weeks (once daily): ~112 syringes
Use ~3.0 mL per 10 mg vial for reconstitution.
8 weeks (8 vials): ~24 mL → 3 bottles
16 weeks (16 vials): ~48 mL → 5 bottles
One for the vial stopper + one for the injection site each day.
Per injection: 2 swabs
8 weeks (once daily): ~112 swabs → 1–2 boxes

Protocol Overview

A concise summary of the once-daily regimen, drawn from commonly cited reference protocols.

▪Goal: Explore reduction of expression lines through gentle, non-paralysing relaxation of facial muscle contraction — an effect documented for topical SNAP-8, not established for the injected route[5][6].
▪Schedule: Daily subcutaneous injections for 8–12 weeks, optionally extended to ~16 weeks for longer research goals.
▪Dose Range: 330–1,000 mcg per day with gradual titration over the cycle.
▪Reconstitution: 3.0 mL bacteriostatic water per 10 mg vial gives ~3.33 mg/mL for accurate unit measurements.
▪Storage: Keep the dry vial frozen at −20 °C (−4 °F); once mixed, refrigerate at 2–8 °C and do not freeze the solution.

Dosing Protocol

A suggested daily titration approach for this educational injectable schedule.

▪Start: Begin at 330 mcg once daily (Weeks 1–4) to gauge tolerability.
▪Titrate: Step up to 500 mcg daily (Weeks 5–8) if well tolerated.
▪Target: Reach 1,000 mcg daily by Weeks 9–12 for maximum effect.
▪Cycle Length: Typically 8–12 weeks; some references extend to ~16 weeks.
▪Timing: Inject at a consistent time each day and rotate injection sites systematically.

Storage Instructions

Correct storage is what preserves the peptide’s stability and activity.

▪Lyophilized: Hold the dry vial at −20 °C (−4 °F) in dry, dark conditions and limit moisture exposure[7].
▪Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F) and use within about 28 days; do not freeze the mixed solution, as freezing can denature peptides[8].
▪Handling: Let frozen vials warm to room temperature before opening so condensation won’t form, and keep the solution clear of heat and direct light.
▪Freeze–thaw: Avoid repeated freeze–thaw cycles of the reconstituted solution.

Important Notes

Practical points that keep daily administration safe and consistent.

▪Sterile technique: Use a fresh sterile U-100 insulin syringe each time and drop it straight into a puncture-proof sharps container afterward.
▪Site rotation: Move between abdomen, thighs and upper arms to reduce local irritation and lipohypertrophy[9].
▪Slow injection: Push the plunger slowly and pause a few seconds before withdrawing the needle to prevent backflow.
▪Recordkeeping: Log the daily dose, injection site and any observations to keep the protocol consistent.
▪Regulatory note: SNAP-8 is a topical cosmetic ingredient with no FDA drug approval; the injected route described here is off-label and unstudied. It is not a WADA-prohibited substance[10].

How This Works

SNAP-8 (Acetyl Octapeptide-3) is a synthetic octapeptide whose sequence mimics the N-terminal end of SNAP-25, a core protein of the SNARE complex that drives the release of acetylcholine at neuromuscular junctions[1][2]. It is an extended analogue of the hexapeptide Argireline (Acetyl Hexapeptide-3/8).

The proposed mechanism is competitive interference with SNARE assembly: by occupying part of the complex, SNAP-8 is thought to attenuate — not cleave — acetylcholine release, softening the muscle contractions behind expression lines[5]. This differs fundamentally from botulinum toxin (Botox), which enzymatically cleaves SNAP-25 and causes lasting muscle paralysis; SNAP-8’s effect is far weaker, non-paralysing and reversible.
Critical context on route of use: in the real world SNAP-8 is sold and studied as a topical cosmetic ingredient, typically formulated at 3–10% in anti-wrinkle serums and creams (INCI name Acetyl Octapeptide-3). The vendor literature for its wrinkle-smoothing activity is based on topical application to the skin surface, not injection.
Important caveat: there is no FDA drug approval for SNAP-8 and no published human efficacy or safety data for the subcutaneous/injected route this page describes. The injectable protocol here is off-label, unstudied and educational; the standard, validated use of SNAP-8 is topical.
SNAP-8 is not an approved medicine. It is a cosmetic peptide presented here for research and educational purposes only.

Lifestyle Factors

Skin-health habits that may complement any anti-wrinkle protocol.

▪Skincare: Keep a consistent routine with quality moisturisers and daily sun protection (SPF) to support skin health.
▪Hydration: Stay well hydrated, since skin elasticity and barrier function depend on adequate fluid intake.
▪Sleep: Aim for 7–9 hours to support the skin’s natural overnight repair processes.
▪Stress: Manage stress with evidence-based practices, since it can affect skin condition and visible ageing.

Potential Benefits & Side Effects

What the cosmetic literature describes for topical SNAP-8; evidence for the injected route is absent and individual results vary.

▪Wrinkle smoothing (topical): Vendor and cosmetic studies report reduced depth of expression lines with topical SNAP-8, attributed to attenuated acetylcholine release and gentler muscle contraction[5][6].
▪Non-paralysing action: Unlike botulinum toxin, SNAP-8 attenuates rather than blocks signalling, so natural facial expression is preserved while line depth is reduced[11].
▪Tolerability (topical): Generally well tolerated as a leave-on cosmetic, with occasional mild local irritation.
▪Note on the injected route: These benefits describe topical use — there are no human trials of injected SNAP-8, and effects of the SC route are unknown[13].
▪Injection-site reactions: For the off-label injected route, mild redness, tenderness or soreness can occur; rotating sites helps.
▪Unknown injectable profile: No human safety data exist for injected SNAP-8, so its risks are genuinely unknown; caution is essential.
▪Regulatory status: SNAP-8 is a cosmetic ingredient with no FDA drug approval; it is not a WADA-prohibited substance.

Injection Technique

General subcutaneous technique, following established clinical best-practice guidance[14][15].

▪Wash your hands well with soap and water.
▪Wipe the vial stopper with an alcohol swab and let it air-dry.
▪Choose a site (abdomen, thigh, or upper arm) and clean it with a fresh alcohol swab, letting it dry fully[15].
▪Draw the intended dose, then check for air bubbles and push any out.
▪Pinch a skinfold at the chosen site between thumb and forefinger.
▪Insert the needle into the pinch at a 45–90-degree angle (use 45 degrees if the fat layer is thin)[14].
▪Skip aspiration for subcutaneous shots — it isn’t needed[14].
▪Press the plunger slowly and steadily until it’s fully down.
▪Wait 5–10 seconds, then pull the needle straight out to prevent leakage.
▪Drop the used syringe straight into a puncture-proof sharps container — never recap a needle.
▪Return the reconstituted vial to the fridge right away.
▪Rotate the injection site each day to prevent irritation and lipohypertrophy[9].
▪Watch the site for excess redness, swelling, or signs of infection.

Recommended Source

For high-purity research peptides, we point researchers to Prime Lab Peptides. Note that SNAP-8 is primarily a cosmetic raw material; check current availability and intended use directly with the supplier.

▪Top-rated on Trustpilot: Independently reviewed as the highest-rated peptide lab on Trustpilot — making it the best current source in the USA. Open source
▪Third-party tested: Every batch ships with a Certificate of Analysis (COA) confirming purity and composition.
▪Consistent quality: ISO-aligned manufacturing and handling keep product integrity reliable batch to batch.
▪Cold-chain integrity: Temperature-controlled shipping and storage across the whole fulfilment chain.
▪Research-grade purity: Fit for educational and research use that demands high-quality peptides.
Note: Product availability and specifications subject to change. Verify current product details on supplier website.
Shop at Prime Lab Peptides →

References

Reference-derived details for SNAP-8 10mg.

SNAP-8 (10mg Vial) Dosage Protocol Open source
1 INCI / CosIng Database Acetyl Octapeptide-3 (SNAP-8) listed as a cosmetic skin-conditioning ingredient for topical formulations. View Source ↗ Open source
2 Lipotec / Cosmetic Technical Literature SNAP-8 (Acetyl Octapeptide-3) anti-wrinkle peptide: proposed mechanism and topical use at 3–10% in serums and creams. View Source ↗ Open source
3 PubMed Cosmeceutical peptides and the SNAP-25 / SNARE pathway in expression-line reduction. View Source ↗ Open source
4 PubMed Argireline (Acetyl Hexapeptide) and related SNARE-targeting peptides as topical anti-wrinkle agents. View Source ↗ Open source
5 Journal of Cosmetic Science (PubMed) SNARE-complex interference and attenuation of acetylcholine release by neuromodulating cosmetic peptides. View Source ↗ Open source
6 Cell / SNARE Biology (PubMed) SNAP-25 and the SNARE complex in neurotransmitter (acetylcholine) release at the neuromuscular junction. View Source ↗ Open source
7 Peptide Storage Guide Best practices for storing lyophilized peptides (temperature, humidity and light protection). View Source ↗ Open source
8 Bacteriostatic Water Guidance Bacteriostatic water for injection: multi-dose vial stability and handling. View Source ↗ Open source
9 NCBI Bookshelf Best practices for subcutaneous injection: aseptic technique and site rotation. View Source ↗ Open source
10 U.S. FDA SNAP-8 (Acetyl Octapeptide-3) has no FDA drug approval; marketed only as a topical cosmetic ingredient. Not a WADA-prohibited substance. View Source ↗ Open source
11 Botulinum Toxin vs Peptides (PubMed) Comparison of botulinum toxin (SNAP-25 cleavage, paralysis) with reversible peptide-based SNARE attenuation. View Source ↗ Open source
12 Topical Peptide Efficacy (PubMed) Clinical and instrumental assessment of topical anti-wrinkle peptides; limitations of efficacy data. View Source ↗ Open source
13 ClinicalTrials.gov Registry search for SNAP-8 / Acetyl Octapeptide-3; no completed efficacy or safety trials of an injected (subcutaneous) route. View Source ↗ Open source
14 Centers for Disease Control and Prevention (CDC) Subcutaneous injection technique: angle, site and no-aspiration guidance. View Source ↗ Open source
15 Subcutaneous Injection Technique (Patient Education) How to administer a subcutaneous injection: clinical technique guidelines. View Source ↗ Open source
16 Prime Lab Peptides Supplier homepage — high-purity research peptides and certificates of analysis. SNAP-8 is primarily a cosmetic raw material; verify availability. View Source ↗ Open source

Contents